BRD-A32161980-001-01-1 (Substance)
(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-3,3-dimethyl-1-oxobutan-2-yl]-1-[(3R,6S,9R,12R,15S)-6-(2-amino-2-oxoethyl)-9-(3-amino-3-oxopropyl)-12-butan-2-yl-15-[(4-methoxyphenyl)methyl]-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentazacycloicosane-3-carbonyl]pyrrolidine-2-carboxamide
Compound (Entity type)Analyze
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View BRD-A32161980-001-01-1's neighborhood in the knowledge graph.
Results found
Linked to
| Label | Description |
|
|---|---|---|---|
 | A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the L1000 Phase1 project | ||
| A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the L1000 Phase1 project | ||
| A biosample from LINCS produced as part of the L1000 Phase1 project | ||
| A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the L1000 Phase1 project |
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the L1000 Phase1 project
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the L1000 Phase1 project
A biosample from LINCS produced as part of the L1000 Phase1 project
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the L1000 Phase1 project